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Reactive oxygen species (ROS) have been implicated in the pathogenesis of many clinical
disorders such as adult respiratory distress syndrome, ischemia-reperfusion injury,
atherosclerosis, neurodegenerative diseases, and cancer. Genetically engineered animal models
have been used as a tool for understanding the function of various antioxidant enzymes in cellular
defense mechanisms against various types of oxidant tissue injury. Transgenic mice
overexpressing three isoforms of superoxide dismutase, catalase, and the cellular glutathione
peroxidase (GSHPx-1) in various tissues show an increased tolerance to ischemia-reperfusion
heart and brain injury, hyperoxia, cold-induced brain edema, adriamycin, and paraquat toxicity.
These results have provided for the first time direct evidence demonstrating the importance of
each of these antioxidant enzymes in protecting the animals against the injury resulting from
these insults, as well as the effect of an enhanced level of antioxidant in ameliorating the oxidant
tissue injury. To evaluate further the nature of these enzymes in antioxidant defense, gene
knockout mice deficient in copper-zinc superoxide dismutase (CuZnSOD) and GSHPx-1 have also
been generated in our laboratory. These mice developed normally and showed no marked
pathologic changes under normal physiologic conditions. In addition, a deficiency in these genes
had no effects on animal survival under hyperoxia. However, these knockout mice exhibited a
pronounced susceptibility to paraquat toxicity and myocardial ischemia-reperfusion injury.
Furthermore, female mice lacking CuZnSOD also displayed a marked increase in postimplantation
embryonic lethality. These animals should provide a useful model for uncovering the identity of
ROS that participate in the pathogenesis of various clinical disorders and for defining the role of
each antioxidant enzyme in cellular defense against oxidant-mediated tissue injury. - Environ
Health Perspect 106(Suppl 5):1219-1228 (1998). http.//ehpnet1.niehs.nih.gov/docs/1998/Suppl-5/
1219-1228ho/abstracthtml
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Reactive oxygen species (ROS), which are equipped with both enzymatic and
produced as by-products of normal nonenzymatic antioxidant defense mecha-
metabolism, are capable of causing cell- nisms to minimize the cellular damage
ular damage, leading to cell death and resulting from interactions between cellular
tissue injury (1). Mammalian cells are constituents and ROS [for review see
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Forman and Fisher (2)]. The enzymatic
antioxidant mechanism contains various
forms ofsuperoxide dismutases (SOD),
catalase, and glutathione peroxidase
(GSHPx), as well as the enzymes involved
in the recycling ofoxidized glutathione,
such as glutathione reductase and glucose
6-phosphate dehydrogenase, a major
enzyme in the pentose phosphate pathway
for the generation ofNADPH.
Despite the presence ofthese delicate
cellular antioxidant systems, an overpro-
duction ofROS in both intra- and extra-
cellular spaces often occurs upon exposure
ofcells or individuals to radiation, hyper-
oxia, and certain chemicals. In mammals,
the activated phagocytic cells present in
local tissue inflammation, as a result ofcell
injury from environmental insults or vari-
ous diseases, can also contribute to an
increased production of ROS. An unbal-
anced production of ROS in localized
compartments has been postulated to play
a role in the pathogenesis of a number of
clinical disorders such as adult respiratory
distress syndrome, ischemia-reperfusion
injury, atherosclerosis, neurodegenerative
diseases, and cancer [for review see Cross
(3)]. This understanding illustrates the
importance of the antioxidant defense
system in maintaining normal cellular
physiology. However, because ofthe over-
lapping activity among some of the anti-
oxidant enzymes, as well as the different
intra- and extracellular sites of ROS pro-
duction and expression of antioxidant
enzymes, it is generally difficult to clearly
define the physiologic role ofeach ofthese
enzymes. For example, three distinct iso-
forms of the superoxide scavenging
enzyme, SOD, are present in the mam-
mals. The copper-zinc SOD (CuZnSOD)
is predominantly expressed in the cytosol
and the manganese SOD (MnSOD) is
located in the mitochondria of the cells
(4,5). In addition, a form ofextracellular
SOD is present in the intravascular and
extracellular fluids such as plasma, lymph,
and synovial fluid (6-8). Although the
protective role ofeach SOD isozyme has
been postulated according to its cellular
site ofexpression, direct evidence demon-
strating their role in vivo in antioxidant
defense mechanism is verylimited.
The enzyme GSHPx, which contains
selenium at the active site, involves the same
complication. GSHPx is believed to play
an important role in cellular antioxidant
defense by reducing H202 and various
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hydroperoxides using glutathione (GSH) as
a reducing agent to form water and
corresponding alcohols, respectively (H202
+2GSH-2H2O+GSSG or ROOH+
2GSH -- ROH + GSSG +H20). There are
at least four isoforms ofGSHPx found in
mammals. The major cellular GSHPx
(GSHPx-1) is expressed in all tissues and
contributes to most ofthe GSHPx activity
present in erythrocytes, kidney, and liver
(9). The plasma GSHPx is detected in
milk, plasma (0.149 U/ml plasma), and
lung alveolar fluid (3.6 mU/ml of25-fold
concentrated lavage fluid) of humans
(10,11). The phospholipid-hydroperoxide
GSHPx, which is capable of reducing
hydroperoxides of phospholipids and
cholesterol, is found mainly in the testis
(12-14). The recently reported gastro-
intestinal tract GSHPx is expressed pre-
dominantly in liver, intestine, and colon
(15,16). Although the physiologic rele-
vance ofGSHPx has been implicated from
the studies performed on animals fed a
selenium-deficient diet (17), due to the
effect of selenium deficiency on other
selenium-containing proteins such as
thioredoxin reductase (18), these studies
are hardlyconclusive.
Our laboratory and several others have
been interested in elucidating the function
ofantioxidant enzymes using transgenic
mouse models in which the expression of
these enzymes is altered by transgenic or
gene targeting technology. This report sum-
marizes some ofthe physiologic conse-
quences from the increased activity of
various antioxidant enzymes in transgenic
animals, as well as our recent work on gen-
eration and characterization ofknockout




Transgenic mice overexpressing various
antioxidant enzymes have been generated
by several laboratories during the past sev-
eral years. The altered responses ofthese
mice to a variety ofoxidant-mediated tissue
injury are summarized inTable 1.
Copper-Zinc Superoxide Dismutase.
Lines ofCuZnSOD transgenic mice were
initially generated by Epstein and colleagues
using a piece of 14.5-kb genomic fragment
containing the entire human CuZnSOD
gene (19). Overexpression of CuZnSOD
activity to various levels has been found in
several major organs including the brain,
heart, lung, and liver. The enhanced
CuZnSOD activity protects animals against
tissue injury induced by a variety of
pathogenic conditions that include cold-
induced brain edema and infarction (20),
focal cerebral ischemic injury (21), neuro-
toxicity of N-methyl-4-phenyl-1,2,3,6-
tetrahydropyridine (22), hyperoxic lung
injury (23), alloxan- or streptozotocin-
induced diabetes (24), and myocardial
ischemia-reperfusion injury (25). These
data clearly indicate the role ofsuperoxide
anion radicals, which are generated in or
diffused to the cytosolic compartment
under these pathogenic conditions, in
causing cell and tissue injury, and the
effect ofthe enhanced CuZnSOD activity
in cellular protection.
However, in other studies the
overexpressed CuZnSOD caused certain
pathologic changes and exacerbated
oxidant-mediated tissue injury. Mice with
elevated CuZnSOD activity exhibit abnor-
mal neuromuscular junction in their
tongues (26), impairment ofmuscle func-
tion (27), thymus and bone marrow
abnormalities (28), a decreased serotonin
uptake by platelets (29), and a retarded
rate in secretion ofprostaglandin by kidney
and cerebellum (30). In addition, these
mice are also more susceptible to kainic
acid-induced excitotoxicity in neurons than
control mice (31). It is not clear whether
the detrimental effect ofCuZnSOD over-
expression is a result ofthe associated free
radical-generating activity of this enzyme
or of its capability in enhancing nitration
oftyrosine byperoxynitrite (32,33).
ManganeseSuperoxideDismutase. We
have generated transgenic mice using a
human MnSOD expression construct
(34,35). Transcription ofthis transgene is
controlled by the 5' flanking sequence and
promoter of the human f-actin gene.
Overexpression of MnSOD activity was
found in the heart, lung, brain, muscle, kid-
ney, spleen, and eye. The overexpressed
MnSOD was further localized by immuno-
cytochemical staining to the mitochondria
of transgenic cardiomyocytes and various
types oflung cells. Because mitochondrion
is one ofthe major subcellular sites capable
ofgenerating superoxide anion radicals, it is
expected that an enhanced MnSOD activity
will be protective in the animals against cer-
tain oxidant-mediated tissue injury. Indeed,
these transgenic mice are more resistant to
cardiotoxicity after treatment with adri-
amycin, a quinone-containing anthracycline
antibiotic, and heart injury resulting from
ischemia-reperfusion (36,37). However,
the overexpressed MnSOD in lung alveolar
type I and type II cells, capillary endothelial
cells, and fibroblasts does not significantly
prolong thesurvival oftransgenic mice com-
pared to nontransgenic littermates upon
exposure to greater than 99% oxygen (35).
This result contradicts that reported by
Wispe and colleagues (38). In their studies,
transgenic mice with an overexpression of
MnSOD in alveolar type II cells and noncil-
iated bronchiolar epithelial cells resulting
from the expression ofa human surfactant
protein C regulatory sequence-driven trans-
gene are markedly more resistant to greater
than 99% oxygen than controls. The reason
forthe discrepancy in the protective effectof
MnSOD in these transgenic mice is not
understood. One possibility is that the mag-
nitude ofincrease in MnSOD immunola-
beling density in mitochondria ofalveolar
type II cells in Wispe's transgenic mice
(400%) is slightly higher than that found in
our homozygous transgenic mice (350%).
Alternatively, it may result from the fact
that different strains ofmice are being used
in Wispe's laboratory (FVB/N) and our
laboratory (B6C3 hybrid).
Extracellular Superoxide Dismutase.
The same human P-actin expression vector
has also been employed to overexpress the
human extracellular superoxide dismutase
(ECSOD) in the brain and heart oftrans-
genic mice (39). Surprisingly, ECSOD
transgenic mice exhibit an increased sus-
ceptibility to oxygen toxicity in the central
nervous system induced by hyperbaric
oxygen compared to that ofnontransgenic
littermates. In this study, inhibitor ofnitric
oxide synthase, an N0,-nitro-L-arginine
methyl ester, protects both nontransgenic
and transgenic mice against hyperbaric
Table 1. Altered responses oftransgenic miceoverexpressing antioxidant enzymes tovarious pathogenic conditions.
Overexpressed Cold-induced Hyperbaric Hydrogen Ischemia-reperfusion
enzyme Hyperoxia brain edema oxygen Adriamycin peroxide Brain Heart
CuZnSOD T(23) 1(20) ND ND ND 1(21) 1(25)
MnSOD -(35), 1(38) ND ND 1(36) ND ND 1 (37)
ECSOD ND 1 (40) 1(39) ND ND ND 1(41)
Catalase ND ND ND 1 (42) ND ND ND
GSHPx-1 -(43) ND ND ND 1 (45) 1(49) 1 (44)
1, more tolerant; .1, more susceptible; -, no changes; ND, not determined.
Environmental Health Perspectives * Vol 106, Supplement 5 * October 1998 1220ANTIOXIDANTTRANSGENIC MODELS
oxygen toxicity. These results suggest that
nitric oxide (*NO) is an important patho-
genic mediator in tissue injury during
exposure ofanimals to hyperbaric oxygen.
It is possible that the enhanced brain activ-
ity ofECSOD in transgenic mice causes a
decrease in the concentration ofsuperoxide
anion radicals. This would prevent the
reaction between superoxide and NO to
form peroxynitrite, resulting in an increase
in NO content and 'NO-mediated toxic-
ity. On the other hand, ECSOD overex-
pression does provide protection to the
animals against cold-induced brain edema
and myocardial ischemia-reperfusion
injury (40,41).
Catalase. Transgenic mice carrying a
rat catalase transgene driven by the 5'
flanking sequence and promoter of the
mouse a-myosin heavy chain gene have
also been established (42). As expected,
the regulatory sequence ofax-myosin heavy
chain gene specifically directs expression of
the transgene in the heart. Further studies
have shown that the increased catalase
activity attenuates adriamycin-induced
cardiotoxicity in these animals.
Celular Glutathione Peroxidase. We
have also generated transgenic mice using
the entire mouse GSHPx-1 gene contained
in a piece of5.3-kb genomic fragment (43).
Overexpression ofGSHPx-1 was found in
the brain, heart, lung, and musde but not in
liver and kidney, where a high level of
expression ofthe endogenous GSHPx-1
enzyme is evident. Although GSHPx-1
transgenic mice show no increased tolerance
to hyperoxic exposure (43), they are more
tolerant to ischemia-reperfusion heart
injury (44), H202-induced DNA strand
breakage in lens epithelial cells (45), and
paraquat toxicity (46). In addition to our
studies, Mirochnitchenko et al. (47) have
also generated transgenic mice carrying a
GSHPx-1 transgene driven by the promoter
of the mouse hydroxy-methylglutaryl-
coenzyme A reductase gene. Increases in
GSHPx activity of4-fold and 1-fold were
found in the brain and skin oftransgenic
mice, respectively. Interestingly, these trans-
genic mice exhibit an increased susceptibil-
ity to hyperthermia and skin carcinogenesis
induced by7,12-dimethylbenz[a]anthracene
and phorbol ester (47,48). However, recent
results have shown that these mice are more
resistant to focal cerebral ischemia-
reperfusion injury (49).
Conclusions and Perspectives. Our
results and those of others (19-49) have
shown that the enhanced expression of
antioxidant enzymes can protect animals
against a variety of tissue injury resulting
from different oxidant insults. These data
have not only confirmed the physiologic
function ofantioxidant enzymes in defend-
ing cells and tissues against oxidant injury
but have also suggested the identity ofthe
injurious ROS in each of the pathogenic
conditions. For example, mouse hearts
overexpressing either one of the SOD
isozymes or GSHPx-1 are more tolerant to
ischemia-reperfusion injury than those of
controls (25,37,41,44). These data clearly
indicate that the endogenous level ofthe
corresponding antioxidant enzyme is not
adequate to detoxify the increased level of
ROS that are generated during the reperfu-
sion period, and that myocardial injury is
mediated by superoxide anion radicals,
H202, and/or fattyacid hydroperoxides.
The pathologic changes found in
CuZnSOD overexpressing mice reported
by Groner and colleagues (26-31) are also
informative with respect to the functional
role of this enzyme. Their studies have
shown that overexpression ofCuZnSOD
results in a chronic oxidative stress (27,31).
The detrimental effect ofCuZnSOD may
be derived from its activity in generating
hydroxyl radicals using H202 as a substrate
(32). This understanding may provide a
potential explanation for the pathologic
changes observed in patients with Down
syndrome, in whom the extra copy of
chromosome 21 gives rise to a 50% increase
ofCuZnSOD activity. Furthermore, these
results mayexclude the use ofCuZnSOD in
antioxidant therapy for treatment of
oxidant-mediated disorders.
In other cases, overexpression ofa single
antioxidant enzyme may not be protective
in the animals. As mentioned previously,
the MnSOD transgenic mice generated in
our laboratory show no significant increase
in tolerance to hyperoxia (35). However,
the transgenic mice created by Wispe and
colleagues (38) with lung-specific overex-
pression ofMnSOD are markedly resistant
to hyperoxic exposure. The discrepancy of
these results may result from the fact that
different strains of mice are used in the
transgenic studies as well as from the
potential difference in the level ofMnSOD
overexpression in the lungcells. These spec-
ulations also bring out three critical issues
in the transgenic studies. First, different
genetic determinants in different strains of
mice may interact directly or indirectly
with the overexpressed proteins to affect
the physiologic outcome found in the
transgenic mice. Second, the critical role of
each antioxidant enzyme in defending cells
and tissues against oxidant injury may differ
in various tissues and is dependent on the
type ofoxidant injury. Third, it is impossi-
ble to precisely control the specificity of
transgene expression in the transgenic mice.
Consequendy, the level ofgene overexpres-
sion may vary in different types ofcells in a
particular tissue. Therefore, a negative result
may not be conclusive as to the protective
role ofan antioxidant enzyme when its
expression is enhanced. This also illustrates
the limitation associated with the studies
using transgenic animals. Toward this end,
we and other laboratories have developed
lines ofknockout mice carrying null muta-
tions in the genes coding for several antioxi-
dant enzymes. Because the defective gene
will affecteverysingle type ofcell in the ani-
mals, the knockout mice may provide an
insightful alternative for defining the nature
of each antioxidant enzyme in cellular
defense mechanisms. Ifthe activity ofa par-
ticularantioxidantenzyme is critical forpro-
tecting the animals against certain oxidants,
adiminished ordecreased enzyme activity as
a result ofgene disruption is expected to





Generation and Characterization of
CuZnSOD-Deficient Mice. As shown in
Figure IA, exon 5 ofthe mouse Sodl gene
and some ofthe flanking intron sequences
were replaced with the neomycin resistance
cassette (neo) (50,51). This also creates a
new PstI restriction site, resulting in a
shorter PstIgenomic fragment from the
targeted allele (12.5 kb) than from the
wild-type allele (16.5 kb). The targeting
vector was linearized with HindIII diges-
tion and transfected into RI embryonic
stem (ES) cells [(52); provided by Dr.
Andras Nagy, Mount Sinai Hospital,
Toronto, Canada]. The homologous
recombinant ES cells were identified by
Southern blot analysis probed with a 5'
DNA fragment external to the genomic
sequence present in the targeting vector.
Chimeric mice were then generated by the
standard gene-targeting technique (53)
and used in breeding with C57B116 female
mice to obtain heterozygous knockout
mice. Mice heterozygous (Sodl+1-) for the
targeted allele were interbred to generate
homozygous knockout (Sod]-1-) mice. An
example of the DNA blot analysis of
mouse DNA is shown in Figure 1B. In
addition to the 16.5-kb wild-type and
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12.5-kb targeted genomic fragments, the 5'
external probe containing exon 1 sequence
also hybridized with a PstIfragment of6.6
kb. This is believed to represent cross-
hybridization between the probe and the
mouse Sod] pseudogene(s) (54).
Expression study was then performed
to determine the effect ofgene disruption
on CuZnSOD expression. As expected, an
approximate 40 to 60% reduction of
CuZnSOD mRNA was found in tissues of
Sod1+- mice compared with that found in
tissues ofwild-type (Sodl+l+) mice (Figure
1C); virtually no CuZnSOD mRNA could
be detected in Sodl-l- mouse tissues.
Reduction ofCuZnSOD activity in tissues
ofSodJI~ and SodI-- mice was also con-
firmed by enzyme activity assay (Table 1).
The very lowlevel ofCuZnSOD activity in
the lung samples of Sod] -- mice presum-
ably represents the activity ofECSOD, as
expression ofthis SOD isoform is relatively
high in the lung compared with that in
other tissues (55). Adecrease in CuZnSOD
activity apparently had no effect on the
expression of other cellular antioxidant
enzymes, including MnSOD (Table 2),
catalase, and GHSPx (data notshown).
CuZnSOD Plays a Critical Role in
Cellular Defense against Paraquat
Toxicity. The ratio of three genotypes of
mice obtained from the interbreeding of
SodP+- mice was in agreement with
Mendelian inheritance, indicating that
there was no lethality in development of
Sod11'- mice. Male and female Sod1-1-
mice grew normally and apparently were
healthy on observation to 18 months of
age. No abnormalities were found by rou-
tine histopathologic tudies in tissues of
CuZnSOD-deficient mice at 4.5 months
ofage including the brain, heart, intestine,
kidney, liver, lung, testis, uterus, and ovary
(data not shown).
We nextdeterminedwhetheradeficiency
in pulmonary CuZnSOD activity would
render animals more susceptible to hyper-
oxic exposure, as transgenic mice overex-
pressing this enzyme survived longer than
control mice under hyperoxic exposure
(23). A virtually identical survival curve
with a median survival time of 3.4 ± 0.1
(SE) days was found in both Sod]+'+ and
Sodt-1 mice, indicating that the function of
this enzyme in lung defense against the
damage from increased production of
superoxide anion radicals duringhyperoxia
is very limited. However, the Sod]-. mice
showed a pronounced sensitivity to
paraquat at a dose of 10 mg/kg bw, with a
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Figure 1. Generation and characterization of CuZnSOD-deficient mice. (A) Schematic showing the genomic and
partial restriction map of the mouse Sodl locus (top), the targeting vector(middle), and the predicted structure of
the targeted locus. Numbered black boxes represent exons. Striped box represents the 5' external sequence used
as a hybridization probe. B, BamHI; E, EcoRI; H, HindlIl; P, Pstl; S, Sacd; Sa, Sail; Sm, Smal; neo, neomycin resis-
tance cassette; TK, herpes thymidine kinase gene underthe transcriptional control ofthe 5'flanking sequence and
promoter of the mouse phosphoglycerate kinase-1 gene. The sizes of hybridizing Pstlrestriction fragments of the
wild-type and the targeted alleles are shown onthe top and bottom ofthe figure, respectively. (B) DNA blotanaly-
sis of mouse offspring. Mouse tail DNA was digested with Pstl and probed with the 5' external probe shown in
(A). +/+, +/-, and -/- represent wild-type, heterozygous, and homozygous knockout mice, respectively. (C) RNA
blot analysis of total cellular RNA isolated from tissues of Sod1+/+, Sodl+- and Sodltl- mice. Twenty-five micro-
grams oftotal RNAfrom each tissue were separated on agarose gel for blot analysis. The RNA blotwas hybridized
with a ratCuZnSOD cDNA probe.
Table2. Superoxide dismutase activities in tissues of Sod1+l', Sodl+1l, and Sodil- mice.a
Enzyme Sodl genotype Brain Liver Lung
CuZnSOD +/+ 23.0 ± 5.4 61.2 ± 15.9 21.9 + 1.7
+/- 10.7 ± 1.2* 28.5±4.5** 11.4± 1.3***
-/- NDt NDt 0.6± 0.4t
MnSOD +/+ 11.3± 3.1 13.0±2.7 9.4 0.9
+/- 11.1 ±2.2 12.9±3.1 9.5 1.3
-/- 11.4±1.4 11.5±1.3 8.3±1.1
ND, CuZnSOD activity was not detected. "Values are means ± SD, and n= 5for all tissue samples. *p<O.O1 when
comparing +/+ to +/- mice. **p<0.01 when comparing +/+ to +/- mice. ***p<0.0001 when comparing +/+ to
+/- mice.tp<0.0001 when comparing +/+to-/-mice, or+/-to-/- mice.
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Figure 2. Increased susceptibility of Sodl-l- mice to
paraquat. The survival times of age-matched, male
Sodl++, Sodl+1-, and Sodl-l- mice following intra-
peritoneal administration of paraquat at a dose of
10 mg/kg were measured.
(Figure 2; p<0.0001 compared with
Sod]+'+ or SodPll mice). Remarkably, the
Sodl-1- mice became listless at about 30
min after peritoneal administration of
paraquat, whereas Sod]+'+ and SodJl+
mice were phenotypically normal even at
the end of 7 days of observation. In
addition, Sodl-1- mice showed a marked
susceptibility to myocardial ischemia-
reperfusion injury (56).
Female Mice Lacking CuZnSOD
Exhibit a Marked Increase in Post-
implantation Embryo Death. Sur-
prisingly, the reproductive performance of
female Sod]-1- mice was inferior to that of
female Sod]+'+ and SodP+1 mice. As
shown in Table 3, male Sod]-1- mice were
as fertile as Sod]+'+ males, and female
Sod1+l+ and Sod1l+ mice were similarly
fertile when bred with either Sod]+'+ or
Sodl-1- male mice. However, the fecun-
dity index (number of litters/number of
copulations) and size of the litters of
Sod]-1- females were much less than those
ofSod]+'+ and SodPl] females. The mech-
anism underlying the poor reproductive
performance was further investigated.
Examination ofvaginal smears indicated
that these three types of mice had similar
estrus cycles, with an average length of 4
to 5 days. In addition, they also mated at
an equivalent frequency (data not shown).
These data indicated that the reduced fer-
tility in SodPlf mice was not a result of
altered estrus cycles. The numbers of ova
ovulated by these mice at each estrus cycle
were then determined and found to be
equivalent (Sod]+'+: 8.0 ± 1.4, n = 6;
Sod]+'-: 7.0± 1.4, n=6; and Sod]-I-:
7.6 ± 2.1, n = 8; p= 0.65). Furthermore,
female Sodtl1 mice also exhibited a normal
ovarian histology, induding number, size, or
morphology ofantral follicles and corpora
lutea, compared with those ofSod]+'+ and
Sod+l- mice. These results suggested that
the reduced fertility in Sodtl- female mice
might result from a defect in embryonic
implantation in the wall of the uterine
horns or premature death ofthe fetuses.
To further evaluate these two
possibilities, we then examined the number
and viability of fetuses in Sod]-'~ female
mice bred with Sod.-h male mice between
12.5 to 15.5 days postcoitus. Of 15 mice
examined, only 2 were not pregnant. A total
of91 embryos were found to be carried by
these female mice. However, 75 embryos in
various sizes were dead and in the process of
being resorbed. Compared to the normal
12.5-day embryos (Figure 3A), most ofthe
dead and resorbed embryos were loosely
attached to the wall ofuterine horns with-
out a developed placenta oryolk sac (Figure
3B). In control experiments, 14 of 15
female Sod+l- mice were pregnant from
breeding with Sod1l- males. A total of 122
implanted embryos were found, and only 9
of these were dead. Although the mean
number ofsuccessfully implanted embryos
in Sod]-1- females (6.3 ± 4.4), including
both the live and dead ones, was less than
that in Sod+l- females (8.2 ±3.0), the dif-
ference was not statistically significant
(p=0.2). These results indicated that the
efficiency ofembryo implantation in the
former mice was equivalent to that in the
latter mice. However, the rate of post-
implantation embryonic death that occurred
in SodPl- females was significantly higher
than that in Sod+l- females (83±23% vs
7.0 ±7.0%, respectively;p<0.0001).
During the course ofour study on the
CuZnSOD-deficient mice, generation and
characterization of a line of mice lacking
the entire Sod] locus were reported by
Reaume and colleagues (57). Their results
showed that mice lacking the CuZnSOD
gene are markedly susceptible to motor
neuron loss after axonal injury and
transient focal cerebral ischemia (57,58).
Although we inactivated the Sod] gene by
a different approach, our results on the
apparently normal phenotype of the
Sodl-Jr mice were in agreement with those
reported previously (57). In addition, we
focused on some other antioxidant func-
tions of this enzyme. Our data revealed
that although the role of CuZnSOD in
defending lungs against lethal exposure of
hyperoxia is negligible, it is essential to
protect animals against paraquat toxicity.
This suggests that the protective role of
CuZnSOD is dependent on the cellular
site of oxygen radical generation. The
mitochondrion is a major subcellular site
producing oxygen radicals under normal
physiologic conditions (1), and the rate of
radical production is further enhanced
in mitochondria of hyperoxic lungs
(59,60). Therefore, MnSOD may play a
more critical role than CuZnSOD in
antioxidant defense mechanism(s) under
normal physiologic conditions and in
defending against lung injury resulting
from hyperoxic insults. This notion is sup-
ported by the recent findings that mice
lacking MnSOD die at very young ages
(61,62). However, CuZnSOD is essential
for animals to survive a lethal exposure to
paraquat, a bipyridyl herbicide capable of
generating oxygen radicals through the
redox cycling mechanism. This reaction is
believed to be catalyzed by the enzyme
NADPH-dependent cytochrome P450
reductase, primarily located in the endo-
plasmic reticulum. Our data suggest that
both the cytosolic and microsomal
enzymes may be the primary targets of
superoxide anion radicals generated during
paraquat toxicity. This conclusion is in
agreement with the earlier study reported
by Phillips and colleagues that Drosophila
lacking CuZnSOD are hypersensitive to
paraquat (63).
Table 3. Reproductive performance of Sod1+l+, Sodl+1-, and Sodl-l- female mice in breeding with Sodl+l+ and
Sodl-l- male mice.
Sodlgenotype Numberof pups
Male Female from each copulation Fecundity indexa Littersizeb
+/+ +/+ 11,9,9,9,8,7,7,6,5,4 100 7.5±2.1
+/+ +/- 9,9,7,7,7,6,5,5,5,0 90 6.7±1.6
+/+ -/- 5,3,3,1,0,0,0,0,0,0,0 36* 3.0±1.6**
-/- +/+ 11,10,9,8,7,7,0 88 8.6±1.5
-/- +/- 14,11,11,9,9,8,8,7,5,2 100 8.4±3.3
-/- -/-- 3,1,1, 1,0,0,0,0,0,0,0 36* 1.5±1.0**
aFecundity index = number of litters/number of copulations x 100. bNumbers are means ± SD. *p< 0.05 when
comparing -/- females to +/+ or +/- females bred with either +/+ or +/- males using one-sided Fisher's exact
test. **p<0.01 when comparing -/-females to+/+ or+/-females bred with either+/+ or+/- males.
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Figure 3. Morphology of normal and resorbed embryos. (A) Morphology of a typical and normal 12.5-day fetus carried by the Sodl+l- female mice. Note the well-developed
placenta, yolk sac, and umbilical cord shown in the middle ofthefetus. (B) An example of dead and resorbed embryos found in the uteri of pregnant Sodlt-/ female mice.
The most intriguing observation in
this study is the reduced fertility offemale
mice lacking this enzyme. Apparently, this
defect is associated with CuZnSOD defi-
ciency in the female mice and is unrelated
to the genotypes of the fetuses. Inter-
estingly, male CuZnSOD-deficient
Drosophila are sterile and females show
markedly reduced fertility (63). These
results and ours suggest that CuZnSOD
plays a critical role in female reproduc-
tion. The mechanism underlying the
observed reduced fertility in female
CuZnSOD-deficient mice, as well as its
implication in human reproductive





Generation and Characterization of
Mice Deficient in Cellular GSHPx. As
shown in Figure 4A, the coding region of
exon 2 of the mouse Gpxl gene was
disrupted by insertion ofa neomycin resis-
tance cassette (64). The HindIII-linearized
targeting vector was then transfected into
RI ES by electroporation. The homologous
recombinant ES clones, which were identi-
fied by Southern blot analysis using a 3'
external probe (Figure 4A, probe 1), were
used to generate chimeric mice. The hetero-
zygous mice that descended from the
chimeric mice were used in breeding to gen-
erate homozygous GSHPx-1 knockout
(Gpx]-) mice. An example of Southern
blot analysis is shown in Figure 4B.
However, for unknown reasons, the 3'
external probe tended to generate a high
hybridization background on the blot filter
carrying mouse tail DNA, contributing to
difficulties in genotyping ofmouse progeny.
The DNA fragment containing exon 2 and
the adjacent 3' sequence (Figure 4A, probe
2) was then used for identifying the tar-
geted allele in knockout mice. The 5.3-kb
Sad and an approximately 11-kb BamHI
hybridizing genomic fragments were
derived from the wild-type Gpxl allele.
Insertion ofthe neomycin resistance cas-
sette resulted in hybridizing SacI and
BamHIfragments from the targeted allele
with sizes of7.1 kb and 4.3 kb, respectively.
Approximately 25% ofthe offspring from
heterozygous breeding were homozygous
for the mutated Gpxl allele, indicating
there was no reduction in viability of
GSHPx-1-deficient mice.
The effect of gene disruption on
GSHPx-1 expression was initially examined
by RNA blot analysis. A 50% reduction of
GSHPx-1 mRNA level was found in
brain, heart, kidney, liver, and lung of
heterozygous knockout (Gpx+l-) mice
compared with those of wild-type
(Gpxl+J+) littermates. Furthermore, no
GSHPx-1 mRNA was found in these
tissues of homozygous knockout mice.
Interestingly, two additional species of
hybridizing RNA of 1.5 kb and 1.9 kb
became visible in liver and kidney samples
of homozygous knockout mice after a
longer exposure of the autoradiograph
(Figure 4C, arrowheads). They presum-
ably represent the aberrant forms offusion
transcript between the mouse Gpxl gene
and the neomycin resistance gene.
The tissue activity of GSHPx in these
mice also reflected the Gpxl genotypes
(Table 4). Virtually no or very low GSHPx
activity could be detected in tissues of
GpxPl- mice. The residual GSHPx activity
may result from the expression of other
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Figure 4. Generation and characterization of GSHPx-1-deficient mice. (A)Targeted disruption ofthe mouse GSHPx-1
gene. Genomic structure and partial restriction map ofthewild-type mouse GSHPx-1 locus(top), thetargeting vec-
tor (middle), and the targeted locus (bottom) are shown. Numbered black boxes represent exons. Shaded boxes
on top of the restriction map of the GSHPx-1 locus represent the sequences used for probing the DNA blot fil-
ters. Probe 1, which is 3' external to the genomic sequence used in thetargeting vector, was used to screen the
ES clones. Probe 2 containing exon 2 and the adjacent 3' sequence was used for genotyping of mouse progeny.
B, BamHI; E, EcoRi; S, Sac. The sizes of Sacl andBamHI restriction fragments of the wild-type and the targeted
alleles hybridized with the probe are shown on the top and bottom of thefigure, respectively. (B) DNA blotanaly-
sis of mouse tail DNA. The Southern blot filter was hybridized with probe 2 as shown in A. +1+, +/-, and -/- repre-
sent wild-type, heterozygous, and homozygous knockout mice, respectively. (C) RNA blot analysis of total cellular
RNA isolated from tissues of Gpxl++, Gpxl+1-, and Gpxt-1 mice. Fifty micrograms of total RNA from each tissue
were separated on an agarose gel for blot analysis. The RNA blot filter was initially hybridized with a rat GSHPx-1
cDNA probe. The types oftissues are shown on the top ofthe autoradiography. The two presumably GSHPx-1-neo
fusion mRNA are shown bythe arrowheads.
GSHPx isozymes in the tissues. These data
also indicate that GSHPx-1 is the major
isozyme ofGSHPx expressed in the tissues
examined. In addition, the activities of
other antioxidant enzymes including
CuZnSOD, MnSOD, and catalase were
unchanged in these five tissues of Gpx+l-
and Gpxl-l- mice compared to those of
Gpxl++ mice (data not shown).
Gpxl-l-Mice Show No Changes in
Susceptibility to Hyperoxia and
Consumption ofExtracellular H202.
Male and female Gpxl-l- mice were
phenotypically normal and healthy on
observation up to 20 months ofage. These
mice were also fertile. Furthermore, no
apparent pathologic changes could be
found in tissues of Gpxl-l- mice, including
brain, heart, intestine, kidney, liver, lung,
and spleen at 4 and 15 months ofage (data
not shown).
GSHPx-1 is highly expressed in
erythrocytes and is believed to play a
protective role against the ROS-mediated
damage in these cells. To determine if a
deficiency in GSHPx-1 would affect the
homeostasis oferythrocytes, a hematologic
profile of the GpxJ+l', Gpxl+-, and
Gpxl-l- mice was obtained. Total blood
cell counts were normal. The numbers of
red cells, reticulocytes, and differential
leukocyte counts including lymphocytes,
monocytes, neutrophils, eosinophils, and
platelets were equivalent in all three types of
mice (data notshown).
The tissue content ofmalondialdehyde
and 4-hydroxyalkenal, a breakdown
product oflipid peroxidation, and protein
carbonyl (a measure ofoxidatively modi-
fied proteins) was found unchanged in tis-
sues of brain, kidney, liver, and lung of
Gpxl-l- mice compared to those of
GpxJl+l mice. These results suggest that
the cellular burden ofoxidative stress may
not be increased in Gpxl-l- mice under
normal physiologic conditions.
We next determined whether a near-
95% decrease in pulmonary GSHPxactivity
would render the animals more susceptible
to hyperoxia. Surprisingly, GpxJl+' and
Gpxl-l- mice exhibited identical median
survival times of4.7 (± 0.3 SE) and 4.7
(± 0.4 SE) days when exposed to greater
than 99% oxygen, respectively.
The effect of a decreased GSHPx-1
activity on the rate of clearance of extra-
cellular H202 at 40 and 10 pM by lung
tissues was also determined. These two
concentrations ofhydrogen were chosen
according to findings that GSHPx-1 has a
lower Km for H202 relative to that of
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Table4. Glutathione peroxidase activity in tissues of Gpxl+l+, Gpxl+1-, and Gpxl-t mice. a
Gpxl
genotype Brain Heart Kidney Liver Lung
+/+ 24.1 ±2.6 32.0 ±3.4 619.4± 129.7 1,202 ±202.2 149.2 ± 17.0
+/- 12.3 ± 1.2** 19.6 ± 2.0** 284.7 ± 14.4* 530.9 ± 90.4** 84.8 ± 14.9*
-/-ND*** 3.9 ± 0.5*** 9.8 ± 1.2*** 8.4 ± 2.0*** 8.6 ± 1.9***
aND, activity was notdetected in four offivesamples.aThe enzyme activity is expressed as nmole NADPH/min/mg
protein assayed at 2 mM GSH. Numbers are means ± SD; n = 5 for all tissues. *p<0.05 when comparing +/+ to
+/- mice. **p<0.01 when comparing +/+ to +/± mice. ***p<0.0001 when comparing +/+ to -/- mice, or +/± to
-/- mice.
catalase and may play a major role in
decomposing H202 at concentrations
below 10 jiM (65). Figure 5 shows that
although the average rates of H202
degradation by knockout lung slices are
slower than those by wild-type lung slices
at both concentrations, these differences
are not statistically significant.
Furthermore, the rates of extracellular
H202 consumption by tissue slices of
heart, liver, and kidney of Gpxl-l- mice
were unchanged compared with those of
GpxJl+' mice (data not shown). However,
when the lens of Gpxl-l- and GpxJl+'
mice were subjected to oxidant insult gen-
erated by photochemical reaction using
riboflavin, the former showed a slower
rate in removing extracellular H202 than
the latter (66,67).
Gpx-- MiceAre More Susceptible
to Acute Paraquat Toxicity and
Myocardial Ischemia-Reperfusion
Injury. Although mice deficient in
GSHPx-1 showed no increased susceptibil-
ity to hyperoxia, they did display a marked
sensitivity to paraquat-induced lethality.
The mean survival time of Gpxl-l- mice
was 5.0 hr in comparison to 69 hr GpxJ+l'
mice at a dose of50 mg/kg bw of paraquat
administrated intraperitoneally (46). The
hearts of Gpx]-'- mice also displayed a
poorer recovery in contractile function fol-
lowing 60 min ischemia-reperfusion com-
pared to Gpxl+l' hearts (68). In addition,
the lens epithelial cells of Gpx-l- mice
were also more susceptible to H202-
induced DNAstand breakage (45).
The physiologic relevance of GSHPx
has previously been implicated from
studies on animals fed with a selenium-
deficient diet. Selenium deficiency results
in a variety ofpathologic changes that
include cardiomyopathy, nutritional
muscular dystrophy, liver necrosis, certain
types of cancers, and female infertility [for
reviews see Burk and Hill (17) and Bedwal
and Bahuguna (69)]. Because GSHPx is
believed to be a key antioxidant enzyme and
many ofthe disorders are associated with an
overproduction ofROS, the largely dimin-
ished activity of GSHPx in selenium
deficiency has been postulated to be respon-
sible for the pathogenesis ofthese diseases.
However, mice deficient in GSHPx-1 were
phenotypically normal and fertile and
showed no signs ofthe diseases found in
selenium-deficient humans and animals,
indicating that these abnormalities may
result from a deficiency ofother selenium-
containing enzymes, or alternatively, from a
combination of GSHPx deficiency and a
second pathogenic condition.
The individual roles of GSHPx and
catalase in cellular antioxidant defense have
never been well established because oftheir
overlapping activity in decomposing
H202. However, because GSHPx exhibits
a lower Km for H202 than catalase and is
capable ofdetoxifying fatty acid hydroper-
oxides, it is generally thought to play a pri-
mary role in minimizing cellular oxidative
damage under normal physiologic condi-
tions. To date, all the biochemical and
physiologic studies for evaluating the con-
tribution ofthese two enzymes to cellular
antioxidant mechanism have relied on the
use of various enzyme and substrate
inhibitors as well as selenium depletion.
The nonspecificity ofthese treatments has
made the interpretation ofthe results more
difficult. The mouse model generated in
this study provides for the first time a
unique experimental system to dissect the
function ofthese two enzymes. Our results
have shown that the role of GSHPx-1 in
animals under normal developmental and
physiologic conditions and in pulmonary
defense against hyperoxia is unexpectedly
limited. In addition, many ofthe functions
of GSHPx previously proposed, such as
protection oferythrocytes from premature
hemolysis or splenic clearance, are not
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Figure 5. Semilogarithmic plots of decomposition of
extracellular H202 by lung slices of Gpxl+1+ and
Gpxl-l- mice. Black circles and squares denote decay
of 40 and 10 pM H202 by Gpxl+1+ lungs, respectively.
Open circles and squares represent decay of 40 and
10 pM H202 by Gpxl-/- lungs, respectively. Values are
means ±SD.
supported by our studies. These observa-
tions clearly demonstrate the overlapping
activity ofcertain cellular enzymatic and
nonenzymatic antioxidant defense mecha-
nisms. Consequently, the deficiency in a
single antioxidant enzyme may not drasti-
cally affect the total cellular capacity of
antioxidant defense. Interestingly, GSHPx-1
deficiency also renders animals more suscep-
tible to paraquat toxicity, indicating the role
of an increased production ofH202 and/or
fatty acid hydroperoxides in paraquat toxic-
ity. However, it should be noted that
Gpx-l- mice are less vulnerable to paraquat
than Sodf-1- mice. Although a dose of 15
mg/kg bw of paraquat hardly causes any
lethality in the former (70), the median sur-
vival time ofthe latter receiving 10 mg/kg
paraquat is 1.4 days. These data indicate
that superoxide anion radicals may play a
more critical role in paraquat toxicity than
H202 and/orfattyacid hydroperoxides.
These studies have illustrated the
application and limitation in the use of
transgenic and gene knockout animal
models in addressing the nature ofantiox-
idant enzymes. It is believed that these
genetically engineered animals will pro-
vide a powerful tool for uncovering the
identity of ROS that participate in the
pathogenesis of many clinical disorders as
well as for defining the role of each
antioxidant enzyme in defending cells and
tissues against tissue injury and diseases
whose progression is associated with an
unbalanced production ofROS.
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